CRVO: CervoMed Inc. Stock

by  •  • Comments Off on CRVO: CervoMed Inc. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 76.41
Enterprise Value ($M) 65.91
Book Value ($M) 34.63
Book Value / Share 3.98
Price / Book 2.21
NCAV ($M) 34.63
NCAV / Share 3.98
Price / NCAV 2.21

Profitability (mra)
Return on Invested Capital (ROIC) -0.54
Return on Assets (ROA) -2.33
Return on Equity (ROE) -3.50

Liquidity (mrq)
Quick Ratio 9.78
Current Ratio 9.78

Balance Sheet (mrq) ($M)
Current Assets 38.58
Assets 38.58
Liabilities 3.94
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 9.74
Operating Income -18.23
Net Income -16.29
Earnings Per Share Basic And Diluted n/a
Earnings Per Share Diluted n/a
Earnings Per Share Basic n/a

Cash Flow Statement (mra) ($M)
Cash From Operations -16.53
Cash from Investing -28.66
Cash from Financing 46.40

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
05-07 13G AWM Investment Company, Inc. 9.90 113.05
02-14 13G/A Ra Capital Management, L.p. 9.90 10.99

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2024-08-09 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2025-05-16 23,036 76,969 29.93
2025-05-15 33,108 175,059 18.91
2025-05-14 86,232 229,349 37.60
2025-05-13 46,244 180,400 25.63

(click for more detail)

Similar Companies
CRBP – Corbus Pharmaceuticals Holdings, Inc. CRDF – Cardiff Oncology, Inc.
CRIS – Curis, Inc. CSBR – Champions Oncology, Inc.
CSCI – COSCIENS Biopharma Inc.


Financial data and stock pages provided by
Fintel.io